News

Ohio AG Yost Warns Med Spas: Stop Misleading Consumers About Weight-Loss Drugs

Ohio Attorney General Dave Yost has sent letters to 14 medical spas throughout the state warning them to stop making false or misleading claims about their versions of popular weight-loss drugs.

The med spas are advertising custom-made variations — called compounded drugs — of semaglutide and/or tirzepatide, the active ingredients in name-brand medications Ozempic®, Wegovy®, Zepbound® and Mounjaro®. But the businesses are incorrectly suggesting that these compounded versions are approved by the Food & Drug Administration and/or just as safe and effective as the brand-name medications.

“People deserve clear and accurate information about the medications they’re putting in their bodies,” Yost said.

“We’re reminding businesses that being truthful isn’t just a good business practice — it’s the law.”

Yost issued letters to the following med spas:

  • Beneficial Health
  • Docere Medical and Aesthetic Center
  • Glow Medispa
  • Jiva Med Spa
  • Limelight Laser and Medical Spa
  • Live Well Chiropractic & Medical
  • New Pathways Clinic
  • Ohio Weight Loss & Wellness Clinic
  • Personalized Vitality Clinic
  • Restore Hyper Wellness OH
  • Summit MedAesthetics
  • TrueForm Health and Wellness
  • Youngstown Medical Weight Loss
  • Zinni Family Practice

What consumers need to know, the attorney general said, is that compounded drugs: 

  • Are not FDA-approved, which means the agency hasn’t tested them for safety or effectiveness.
  • Are not the same as Ozempic®, Wegovy®, Zepbound® or Mounjaro®, which are FDA-approved. Compounded versions may not meet the standards that brand names have met.
  • Are not the same as generic drugs. Generic drugs are FDA-approved and, as such, are held to the same standards as brand-name versions. Compounded drugs, made by pharmacies for individual patients, are not subject to the same oversight.

While compounded drugs can serve an important medical need for patients who cannot be treated with FDA-approved medications, businesses should not make false promises or misleading claims about such drugs’ safety or efficacy.

Support the New Americans magazine to continue to serve our community with precise news that affect the new American, immigrant and refugee community. https://paypal.com/donate/?hosted_button_id=8LHFS78NRNJJY&source=url

New Americans Magazine
Deba Uwadiae is an international journalist, author, global analyst, consultant, publisher and Editor-in-Chief of the New Americans Magazine Group, Columbus, Ohio. He is a member of the Ohio Legislative Correspondents Association, OCLA.

    You may also like

    Leave a reply

    This site uses Akismet to reduce spam. Learn how your comment data is processed.